Φορτώνει......
A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema
BACKGROUND: Patients with hereditary angioedema with C1 inhibitor deficiency or dysfunction have burdensome recurrent angioedema attacks. The safety, efficacy, and health‐related quality of life (HRQoL) outcomes of C1 inhibitor (C1‐INH) prophylaxis (intravenously administered) in patients aged 6‐11 ...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Pediatr Allergy Immunol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6851661/ https://ncbi.nlm.nih.gov/pubmed/30968444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pai.13060 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|